Patent · US Active

Sustained-release formulation

US9427406B2 · kind B2 · utility

1Cited by

6References

30Claims

0Family size

Assignee

NAUTILUS CAPITAL CORPORATION · US

Inventors

Andrey Gavryushin · Planegg, DE
Johannes Kobler · Munich, DE
Juergen Sauer · Beilngries, DE

Key dates

Filing date	Oct 11, 2014
Grant date	Aug 30, 2016
Priority date	—
Expiry date	Oct 11, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/906
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A substantially monodisperse assemblage of particles 10 having interconnected pores 20 and a core 30 with at least one shell 40, 60 disposed about the core 30 as well as a method for their synthesis is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.